Exercise and education program for lateral hip pain
Official title: 3 Months Semi-supervised Exercise Intervention for Patients With Hip Abductor Tendon Pathology (HATP): A Prospective Clinical Cohort Study
Run by Horsens Hospital · NCT06418217 · Data updated 2026-11-12
This study is testing whether a special exercise program and education can help people with lateral hip pain feel better after 12 weeks of treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Horsens Hospital Academic / other |
| Locations | 1 site (Horsens, Horsens) |
| Status | Recruiting |
| Started | May 17, 2024 |
| Main results expected | November 1, 2026 |
| Study ends | February 1, 2027 |
| Registry record updated | June 26, 2025 |
| Trial ID | NCT06418217 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-75 with MRI-verified hip abductor tendon pathology and a history of lateral hip pain lasting more than six months.
✕Probably not a fit
Patients with recent corticosteroid injections, previous hip surgeries, or signs of hip osteoarthritis may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional cohort trial aims to evaluate the effectiveness of a progressive exercise protocol combined with patient education for individuals suffering from hip abductor tendon pathology. Participants will undergo eight physiotherapist-led exercise sessions over 12 weeks at Horsens Regional Hospital, with additional home exercises to be performed daily. The primary outcome will be assessed using the revised Copenhagen Hip And Groin Outcome Score (HAGOS) to measure changes in hip pain from baseline to follow-up. The study will also explore how different factors like MRI findings and demographics may influence treatment responses.
Why it matters
Potential benefit: If successful, this program could significantly reduce hip pain and improve function for patients with lateral hip pain.
How similar studies have gone: Previous studies have shown positive outcomes with similar exercise and education interventions for musculoskeletal pain, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-75 years * MRI verified HATP * Lateral hip pain duration \> 6 months * Ability to read and understand Danish. Exclusion Criteria: * Corticosteroid injection in the affected hip joint within the last six weeks prior to the intervention * Previous bone-related surgery to the affected hip, * Signs of bilateral HATP * X-ray verified hip osteoarthritis * Pregnancy
Where it's running
-
Horsens Regional Hospital
Horsens, Horsens, Denmark Recruiting
Study contacts
- Principal investigator: Mathias Høgsholt, PT, PhD.st. — Horsens Regional Hospital; Aarhus University
- Study coordinator: Mathias Høgsholt, PT,PhD.-st.
- Email: mathhg@rm.dk
- Phone: +45 24205299
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High-Intensity Laser Therapy for Greater Trochanteric Pain Syndrome
This trial tests whether high-intensity laser therapy can reduce pain and improve function for adults with GTPS compared with a sham treatment.
-
ReneuRx for lateral hip pain: a treatment option for people with GTPS
This study tests whether the ReneuRx device can relieve moderate to severe lateral hip pain in adults compared with a corticosteroid injection.
-
ESWT versus conventional physical therapy for Greater Trochanteric Pain Syndrome
This trial will try Extracorporeal Shockwave Therapy (ESWT) against usual physical therapy to see which reduces pain and improves function in adults with Greater Trochanteric Pain Syndrome.
-
Evaluating TENEX for hip pain relief
This study is testing if a special ultrasound-guided procedure called TENEX can help people with chronic hip pain feel better and move easier when other treatments haven't worked.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.